Engineering the gut microbiota to treat chronic diseases

被引:0
作者
Noura S. Dosoky
Linda S. May-Zhang
Sean S. Davies
机构
[1] Vanderbilt University,Department of Pharmacology and Division of Clinical Pharmacology
来源
Applied Microbiology and Biotechnology | 2020年 / 104卷
关键词
Gut microbiota; Engineered bacteria; Cancer; Diabetes; Inflammatory bowel disease; Atherosclerosis; Obesity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:7657 / 7671
页数:14
相关论文
共 804 条
[1]  
Arrach N(2008) promoters preferentially activated inside tumors Cancer Res 68 1363-119
[2]  
Zhao M(2013)Probiotics: properties, examples, and specific applications Cold Spring Harb Perspect Med 3 a010074-759
[3]  
Porwollik S(2019)Gut microbiota metabolite regulation of host defenses at mucosal surfaces: implication in precision medicine Precis Clin Med 2 110-120
[4]  
Hoffman R(2006)A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease Clin Gastroenterol Hepatol 4 754-83
[5]  
McClelland M(2015)Rescuing chemotaxis of the anticancer agent J Biotechnol 211 117-1103
[6]  
Behnsen J(2017) serovar Typhimurium VNP20009 J Biotechnol 251 76-243
[7]  
Deriu E(2012)Optimizing the restored chemotactic behavior of anticancer agent Science 335 1099-570
[8]  
Sassone-corsi M(2009) serovar Typhimurium VNP20009 J Gen Virol 90 234-G738
[9]  
Raffatellu M(2010)Global network reorganization during dynamic adaptations of Oral Oncol 46 564-9608
[10]  
Bilotta AJ(2015) metabolism Microb Cell Factories 14 137-265